# DisCoVisc Versus DuoVisc, Healon5 and AmVisc Plus

> **NCT00712244** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 112 (actual)

## Conditions studied

- Cataract

## Interventions

- **DEVICE:** DisCoVisc
- **DEVICE:** DuoVisc
- **DEVICE:** Healon5
- **DEVICE:** Amvisc Plus

## Key facts

- **NCT ID:** NCT00712244
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-04
- **Final completion:** —
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2010-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00712244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00712244, "DisCoVisc Versus DuoVisc, Healon5 and AmVisc Plus". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00712244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*